1. Home
  2. KGS vs PRAX Comparison

KGS vs PRAX Comparison

Compare KGS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak Gas Services Inc.

KGS

Kodiak Gas Services Inc.

HOLD

Current Price

$76.01

Market Cap

7.2B

Sector

N/A

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$327.28

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KGS
PRAX
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.1B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
KGS
PRAX
Price
$76.01
$327.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
15
Target Price
$57.17
$572.13
AVG Volume (30 Days)
1.6M
560.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.93%
N/A
EPS Growth
58.93
N/A
EPS
0.20
N/A
Revenue
$1,308,100,000.00
N/A
Revenue This Year
$12.30
N/A
Revenue Next Year
$7.96
$7,758.26
P/E Ratio
$370.00
N/A
Revenue Growth
12.83
N/A
52 Week Low
$30.06
$37.25
52 Week High
$77.68
$366.52

Technical Indicators

Market Signals
Indicator
KGS
PRAX
Relative Strength Index (RSI) 63.77 57.49
Support Level $65.10 $308.40
Resistance Level $77.18 $327.65
Average True Range (ATR) 2.58 17.85
MACD 0.70 8.65
Stochastic Oscillator 99.42 83.99

Price Performance

Historical Comparison
KGS
PRAX

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: